Joseph G. Pressey · Dramatic multifocal osteosarcoma treatment response in the setting of POT1 tumor predisposition syndrome
Follow
Article1 min read·Published Aug 2025

Dramatic multifocal osteosarcoma treatment response in the setting of POT1 tumor predisposition syndrome

pubmed.ncbi.nlm.nih.gov shows its articles on its own site.

Read the article on pubmed.ncbi.nlm.nih.gov ↗

Article · Aug 2025 · 1 min read

In brief

In brief

This case report describes a 15-year-old male with POT1 tumor predisposition syndrome who developed synchronous multifocal osteosarcoma—typically associated with poor prognosis—but achieved long-term remission following standard chemotherapy. The dramatic treatment response may represent a unique chemosensitive phenotype in POT1-related osteosarcoma.

Written by the GCMD Library team from the article.

Joseph G. Pressey

Introduction: POT1 tumor predisposition (POT1-TPD) is associated with a spectrum of malignancies due to loss of function mutations in POT1 leading to telomere elongation and genomic instability. Osteosarcoma is the most common primary malignant bone tumor and has a poor prognosis when multifocal. Case Presentation: A 15-year-old male was found to have a primary right distal femur osteosarcoma with multiple additional bony sites of disease. A POT1 splice site variant (c.949+1G>C) was identified both somatically and in the germline consistent with POT1-TPD. Despite extensive multifocality, the tumor displayed marked chemosensitivity to standard of care therapy and long-term remission was achieved. Discussion: Evidence suggests that hereditable alterations in telomeric function including POT1 are enriched in sarcoma susceptibility. Furthermore, hereditary tumor predisposition syndromes often increase osteosarcoma risk including a recent report of five patients with POT1-TPD. Multifocal osteosarcoma is rare, but a few retrospective cohorts suggest dismal prognosis. This report details an adolescent male with presumed POT1-TPD who developed synchronous multifocal osteosarcoma exquisitely sensitive to chemotherapy which may represent a unique phenotype for the syndrome.

Statements in this article

  1. POT1 tumor predisposition is associated with a spectrum of malignancies due to loss of function mutations in POT1 leading to telomere elongation and genomic instability.

    EstablishedIntroduction
  2. Osteosarcoma is the most common primary malignant bone tumor and has a poor prognosis when multifocal.

    EstablishedIntroduction
  3. A POT1 splice site variant (c.949+1G>C) identified both somatically and in the germline is consistent with POT1 tumor predisposition syndrome.

    ResearchCase Presentation
  4. Multifocal osteosarcoma with POT1 tumor predisposition syndrome displayed marked chemosensitivity to standard of care therapy and long-term remission was achieved.

    ResearchCase Presentation
  5. Hereditable alterations in telomeric function including POT1 are enriched in sarcoma susceptibility.

    EstablishedDiscussion
  6. Hereditary tumor predisposition syndromes often increase osteosarcoma risk.

    EstablishedDiscussion
  7. Five patients with POT1 tumor predisposition syndrome have been reported with osteosarcoma.

    ResearchDiscussion
  8. Multifocal osteosarcoma is rare and retrospective cohorts suggest dismal prognosis.

    EstablishedDiscussion
  9. Synchronous multifocal osteosarcoma exquisitely sensitive to chemotherapy may represent a unique phenotype for POT1 tumor predisposition syndrome.

    OpenDiscussion

Read it at the source ↗

Try
Intelligent Search· scoped to this article · not medical adviceSearch the whole library →
GCMD Library — educational content from recorded physician discussions, not medical advice.